Public health, innovation, intellectual property and trade

Ethiopia set to develop pharmaceutical industry to increase access to medicines

The Democratic Republic of Ethiopia, on 14 July 2015, launched an ambitious 10-year national strategy and plan of action to develop local pharmaceutical manufacturing capacity in order to increase access to locally manufactured, quality-assured medicines. The launch occurred on the side-lines of the 3rd Conference on Financing for Development.

Launch of Ethiopia’s National Strategy and Plan of Action for Pharmaceutical Manufacturing

On the occasion of the international conference on financing for development in Addis Ababa, the Prime Minister of Ethiopia with the World Health Organization (WHO) launched a 10-year strategic plan to develop its pharmaceutical manufacturing capacity in order to increase access to local quality-assured medicines. The launch took place on 14 July at 7 p.m. local time and was attended by numerous heads of international agencies.

WHO updates patent information on sofosbuvir and ledipasvir for the treatment of Hepatitic C Virus

World Hepatitis Alliance

New medicines on the market have given new hope to the millions of people who suffer from Hepatitis C Virus (HCV), a chronic disease that often leads to severe liver disease and kills between 350 000-500 000 people annually.
WHO works closely with Member State governments to assess and promote policy options for increasing access to these medicines, which remain unaffordable to many of those who need them and put an enormous financial strain even on the health systems of high-income countries.

Technical Consultation on Innovative Models for New Antibiotics’ Development and Preservation

A one day “Technical Consultation on Innovative Models for New Antibiotics’ Development and Preservation” was held at WHO headquarters on 13 May 2014. The meeting brought together leading experts to present and discuss innovative models fostering discovery and development of new antibiotics as part of the toolkit to address challenges related to antimicrobial resistance (AMR). This meeting was held in the context of the Global action plan for AMR (GAP-AMR) that WHO is mandated to develop before the next World Health Assembly. The research and development of new antimicrobials and their preservation is going to be an important pillar of the GAP-AMR.

Latest activities